PLIVA, the leading pharmaceutical company in Croatia and an important member of Teva group, one of the largest global pharmaceutical companies, was founded 96 years ago, in 1921. PLIVA CROATIA is a limited liability company and has been a member of Teva group since 2008.
The strength of the company lies in diversity, exceptional expertise and high dedication of its employees who are committed to achieving business goals. They have been taking credit for PLIVA’S success for generations.
PLIVA’s business activities include manufacturing of finished forms of drugs and active pharmaceutical ingredients, commercial operations (marketing and sales on the Croatian and the SEE markets), and research and development of generic drugs and active pharmaceutical ingredients (APIs). PLIVA’s APIs and intermediates have been present on the most demanding US and European markets since mid-1960s.
PLIVA is the only pharmaceutical company in Croatia with vertically integrated production. In other words, a product is first developed in R&D, followed by producing active ingredients in TAPI, and final manufacturing of a finished drug. Zagreb production site specialises in oral solid forms, sterile products, crèmes and ointments.
For years now PLIVA has been among top Croatian drug producers based on total revenue and export, and it has been recording continual growth of total revenue, export and, importantly, investments that create new jobs.
Data for 2014 indicate that while the total revenue of ten leading producers in the Croatian market increased by 12.1 %, PLIVA achieved the growth of 19.1 %, with the total revenue amounting to HRK 3.8 billion. As such PLIVA was the main generator of growth of the domestic market. In 2015 PLIVA additionally strengthened its export, exporting goods in the amount of HRK 3 billion to a number of markets, including US and Russia as the largest ones. For these results in 2014 and 2015 PLIVA won the award of the biggest exporter in the category of large companies.
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a global pharmaceutical company specialised in development, production and sale of generic and innovative active pharmaceutical ingredients. Headquartered in Israel, Teva is one of the leading pharmaceutical companies whose products are used daily by 200 million people in 100 markets around the world.
With more than one hundred years of experience in improving health and making people feel better, the company is present in a number of international markets, where it operates through the network of affiliated companies. With more than 1800 molecules in its portfolio, Teva is the largest global producer of generic drugs in nearly all therapeutic areas. TEVA’s net revenue in 2016 amounted to USD 21.9 billion.
For more information about Teva go to www.tevapharm.com